ZA914349B - Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof - Google Patents
Ws7622a mono-or di-sulfate,process for preparation thereof and use thereofInfo
- Publication number
- ZA914349B ZA914349B ZA914349A ZA914349A ZA914349B ZA 914349 B ZA914349 B ZA 914349B ZA 914349 A ZA914349 A ZA 914349A ZA 914349 A ZA914349 A ZA 914349A ZA 914349 B ZA914349 B ZA 914349B
- Authority
- ZA
- South Africa
- Prior art keywords
- sulfate
- preparation
- ws7622a
- mono
- ws7622a mono
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 241000946782 Streptomyces resistomycificus Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909014546A GB9014546D0 (en) | 1990-06-29 | 1990-06-29 | Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA914349B true ZA914349B (en) | 1992-03-25 |
Family
ID=10678456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA914349A ZA914349B (en) | 1990-06-29 | 1991-06-06 | Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US5292510A (xx) |
| EP (1) | EP0465895B1 (xx) |
| JP (1) | JP2663763B2 (xx) |
| KR (1) | KR100198693B1 (xx) |
| CN (1) | CN1073115C (xx) |
| AT (1) | ATE138074T1 (xx) |
| AU (1) | AU640241B2 (xx) |
| CA (1) | CA2045761C (xx) |
| DE (1) | DE69119488T2 (xx) |
| DK (1) | DK0465895T3 (xx) |
| ES (1) | ES2087178T3 (xx) |
| FI (1) | FI106554B (xx) |
| GB (1) | GB9014546D0 (xx) |
| GR (1) | GR3020184T3 (xx) |
| HU (1) | HU213398B (xx) |
| IE (1) | IE75702B1 (xx) |
| IL (1) | IL98394A (xx) |
| NO (1) | NO301643B1 (xx) |
| PH (1) | PH31239A (xx) |
| PT (1) | PT98134B (xx) |
| RU (1) | RU2087482C1 (xx) |
| ZA (1) | ZA914349B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE161016T1 (de) * | 1991-06-18 | 1997-12-15 | Fujisawa Pharmaceutical Co | Ws7622a enthaltende prophylaktische/therapeutische zusammensetzung zur vorbeugung und behandlung von verstreuter, intravaskulärer koagulation, chronischer, infektiöser atemwegskrankheiten oder chronischer bronchitis |
| US5384119A (en) * | 1993-08-12 | 1995-01-24 | Merrell Dow Pharmaceuticals Inc. | Method of preventing neutrophil mediated connective tissue damage |
| JP2002161051A (ja) * | 1996-12-24 | 2002-06-04 | Fujisawa Pharmaceut Co Ltd | 脳虚血性疾患等の治療剤 |
| EP1057491B1 (en) * | 1998-02-24 | 2013-06-19 | Astellas Pharma Inc. | Preventives/remedies for skin aging |
| CN109406709B (zh) * | 2018-12-27 | 2020-11-10 | 福建省中医药研究院(福建省青草药开发服务中心) | 一种太子参药材中氨基酸类成分的薄层鉴别方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH27266A (en) * | 1989-03-14 | 1993-05-04 | Fujisawa Pharmaceutical Co | WS7622, A,B,C and D substances and pharmaceutical composition containing same |
-
1990
- 1990-06-29 GB GB909014546A patent/GB9014546D0/en active Pending
-
1991
- 1991-06-04 PH PH42571A patent/PH31239A/en unknown
- 1991-06-06 IL IL9839491A patent/IL98394A/en unknown
- 1991-06-06 ZA ZA914349A patent/ZA914349B/xx unknown
- 1991-06-11 US US07/713,295 patent/US5292510A/en not_active Expired - Fee Related
- 1991-06-14 IE IE204791A patent/IE75702B1/en not_active IP Right Cessation
- 1991-06-17 FI FI912914A patent/FI106554B/fi active
- 1991-06-18 JP JP3245283A patent/JP2663763B2/ja not_active Expired - Fee Related
- 1991-06-21 DE DE69119488T patent/DE69119488T2/de not_active Expired - Fee Related
- 1991-06-21 ES ES91110243T patent/ES2087178T3/es not_active Expired - Lifetime
- 1991-06-21 EP EP91110243A patent/EP0465895B1/en not_active Expired - Lifetime
- 1991-06-21 DK DK91110243.2T patent/DK0465895T3/da active
- 1991-06-21 AT AT91110243T patent/ATE138074T1/de not_active IP Right Cessation
- 1991-06-26 CA CA002045761A patent/CA2045761C/en not_active Expired - Fee Related
- 1991-06-27 AU AU79394/91A patent/AU640241B2/en not_active Ceased
- 1991-06-27 RU SU4895704/04A patent/RU2087482C1/ru not_active IP Right Cessation
- 1991-06-28 PT PT98134A patent/PT98134B/pt not_active IP Right Cessation
- 1991-06-28 KR KR1019910010900A patent/KR100198693B1/ko not_active Expired - Fee Related
- 1991-06-28 NO NO912561A patent/NO301643B1/no not_active IP Right Cessation
- 1991-06-28 HU HU912198A patent/HU213398B/hu not_active IP Right Cessation
- 1991-06-28 CN CN91104323A patent/CN1073115C/zh not_active Expired - Fee Related
-
1993
- 1993-07-07 US US08/087,006 patent/US5364624A/en not_active Expired - Fee Related
-
1996
- 1996-06-07 GR GR960401547T patent/GR3020184T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL104437A0 (en) | 4"-deoxyerythromycin derivatives | |
| GR3023353T3 (en) | Cyclic peptide antagonists of Substance P and Substance K | |
| TW252979B (xx) | ||
| GB9014546D0 (en) | Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof | |
| HUT63462A (en) | Process for producing new glycopeptides and pharmaceutical compositions comprising same as active ingredient | |
| IL93548A0 (en) | Ws7622a,b,c and d substances,derivatives thereof,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT57227A (en) | 2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance | |
| IL86169A (en) | Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them | |
| EP0418990A3 (en) | 13-bromo and 13,14-dibromo ergoline, their preparation and their use | |
| HUT49886A (en) | Process for producing new beta-lactam antibiotics and pharmaceutical compositions comprising same | |
| IE901180L (en) | Polar cephalosporin derivatives and a process for the¹preparation thereof | |
| ZA828237B (en) | A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom | |
| HUT53654A (en) | Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds | |
| IT1254565B (it) | Forma cristallina dell'endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato |